In the last trading session, 1.05 million Applied Molecular Transport Inc. (NASDAQ:AMTI) shares changed hands as the company’s beta touched 2.04. With the company’s per share price at $0.21 changed hands at $0.01 or 5.22% during last session, the market valuation stood at $9.05M. AMTI’s last price was a discount, traded about -561.9% off its 52-week high of $1.39. The share price had its 52-week low at $0.18, which suggests the last value was 14.29% up since then. When we look at Applied Molecular Transport Inc.’s average trading volume, we note the 10-day average is 2.74 million shares, with the 3-month average coming to 565.84K.
Analysts gave the Applied Molecular Transport Inc. (AMTI) stock a consensus recommendation rating of a Hold, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended AMTI as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. Applied Molecular Transport Inc.’s EPS for the current quarter is expected to be -$0.5.
Applied Molecular Transport Inc. (NASDAQ:AMTI) trade information
Instantly AMTI was in green as seen at the end of in last trading. With action 5.22%, the performance over the past five days has been green. The jump to weekly highs of 0.2599 on Monday, 09/18/23 added 5.22% to the stock’s daily price. The company’s shares are showing year-to-date downside of -49.14%, with the 5-day performance at 5.22% in the green. However, in the 30-day time frame, Applied Molecular Transport Inc. (NASDAQ:AMTI) is -14.70% down. Looking at the short shares, we see there were 0.23 million shares sold at short interest cover period of 2.81 days.
The consensus price target for the stock as assigned by Wall Street analysts is $1.00, meaning bulls need an upside of 79.0% from its current market value. According to analyst projections, AMTI’s forecast low is $1.00 with $1.00 as the target high. To hit the forecast high, the stock’s price needs a -376.19% plunge from its current level, while the stock would need to soar -376.19% for it to hit the projected low.
Applied Molecular Transport Inc. (AMTI) estimates and forecasts
Data shows that the Applied Molecular Transport Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -42.27% over the past 6 months, a 70.77% in annual growth rate that is considerably higher than the industry average of 11.90%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Applied Molecular Transport Inc. will rise 23.10%, while the growth in revenue is estimated to hit 12.10% for the next quarter.
The 2023 estimates are for Applied Molecular Transport Inc. earnings to decrease by -21.90%, but the outlook for the next 5-year period is at 38.70% per year.
Applied Molecular Transport Inc. is expected to release its next quarterly earnings report between November 06 and November 10.
Applied Molecular Transport Inc. (NASDAQ:AMTI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.92% of Applied Molecular Transport Inc. shares while 44.51% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 57.00%. There are 44.51% institutions holding the Applied Molecular Transport Inc. stock share, with EPIQ Capital Group, LLC the top institutional holder. As of Jun 29, 2023, the company held 22.05% of the shares, roughly 8.69 million AMTI shares worth $2.24 million.
Founders Fund V Management, LLC holds the second largest percentage of outstanding shares, with 9.16% or 3.61 million shares worth $0.93 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 1.09 million shares estimated at $0.28 million under it, the former controlled 2.76% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.56% of the shares, roughly 0.22 million shares worth around $57443.0.